Eupraxia Pharmaceuticals (EPRX) Payables (2022 - 2026)
Eupraxia Pharmaceuticals (EPRX) posted Payables of $8.39 million for the quarter ended Jun 30, 2026, up 224.8% from $2.58 million a year earlier and up 17.2% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Payables (2022 - 2026) Analysis & Trends
As of Dec 31, 2025, Eupraxia Pharmaceuticals' Payables came in at $5.55 million, up 83.1% from the prior year.
- Annual Payables shows a three-year compound annual growth rate of 23.7% (years ended Dec 2022 to Dec 2025).
- In prior years, Eupraxia Pharmaceuticals' Payables was $3.03 million in the year ended Dec 31, 2024 (-22.7%), $3.92 million in the year ended Dec 31, 2023 (+33.9%) and $2.93 million in the year ended Dec 31, 2022.
- The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly Payables in data going back to the quarter ended Dec 31, 2022.
- On a year-over-year basis, Payables has increased in each of the last five quarters, with growth averaging 80.9% over the last seven quarters.
- The strongest year-over-year quarter for Payables in the past five years was the quarter ended Mar 31, 2026, with growth of 233.4%; the weakest was the quarter ended Mar 31, 2025, with a decline of 45.9%.
- According to Business Quant data, Payables for the three prior quarters was $7.16 million (quarter ended Mar 31, 2026), $5.55 million (quarter ended Dec 31, 2025) and $3.73 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Eupraxia Pharmaceuticals | 328.04 Mn | 326.44 Mn | - | 8.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.39 Mn |
| Mar 31, 2026 | 7.16 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Sep 30, 2025 | 3.73 Mn |
| Jun 30, 2025 | 2.58 Mn |
| Mar 31, 2025 | 2.15 Mn |
| Dec 31, 2024 | 3.03 Mn |
| Sep 30, 2024 | 2.29 Mn |
| Jun 30, 2024 | 1.98 Mn |
| Mar 31, 2024 | 3.97 Mn |
| Dec 31, 2023 | 3.92 Mn |
| Dec 31, 2022 | 2.93 Mn |
API Access
Eupraxia Pharmaceuticals Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();